Skip to main content

Weekly Respiratory Research Analysis

3 papers

This week’s respiratory literature highlights rapid advances in noninvasive diagnostics, phenotypic imaging, and zoonotic surveillance. High‑accuracy tongue‑swab qPCR and serum MAP‑TB assays broaden non‑sputum diagnostics for TB, while a covalent TKI‑derived probe enables near real‑time phenotypic detection of EGFR mutations from tissue. Large clinical and surveillance studies (maternal RSV vaccination, H5N1 case characterization) further inform prevention and occupational safety priorities.

Summary

This week’s respiratory literature highlights rapid advances in noninvasive diagnostics, phenotypic imaging, and zoonotic surveillance. High‑accuracy tongue‑swab qPCR and serum MAP‑TB assays broaden non‑sputum diagnostics for TB, while a covalent TKI‑derived probe enables near real‑time phenotypic detection of EGFR mutations from tissue. Large clinical and surveillance studies (maternal RSV vaccination, H5N1 case characterization) further inform prevention and occupational safety priorities.

Selected Articles

1. Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study.

84.5The European Respiratory Journal · 2025PMID: 39746762

A 7‑center prospective study (n=729) showed the TB‑EASY tongue‑swab qPCR achieved sensitivity/specificity of 89.6%/96.2% versus sputum Xpert and 87.4%/98.0% versus a microbiological reference, with sensitivity varying by bacterial load (100% high load to 70.4% very low). The assay offers a reliable noninvasive alternative when sputum is difficult to obtain.

Impact: Provides a scalable, high‑accuracy, noninvasive TB diagnostic that can expand case finding and reduce reliance on sputum in high‑burden settings.

Clinical Implications: Programs should consider introducing tongue‑swab qPCR for patients who cannot produce sputum and for decentralized screening, with attention to bacterial‑load effects and cost‑effectiveness evaluations.

Key Findings

  • Sensitivity/specificity 89.6%/96.2% versus sputum Xpert; 87.4%/98.0% versus microbiological reference.
  • Sensitivity varied with bacterial load: 100% in high‑load cases to 70.4% in very‑low‑load cases.
  • Prospective multicentre design across seven TB hospitals (n=729).

2. Image-Based Phenotypic Profiling Enables Rapid and Accurate Assessment of EGFR-Activating Mutations in Tissues from Lung Cancer Patients.

82Journal of the American Chemical Society · 2025PMID: 39745025

A covalent, quenched TKI‑derived fluorescent probe enables no‑wash, real‑time imaging of EGFR in cells and tissues, distinguishing mutant from wild‑type tumors and predicting EGFR mutations in patient biopsies with ~94% accuracy (98% with IHC). This phenotypic approach can accelerate functional mutation assessment from biopsy material.

Impact: Introduces a translational diagnostic that provides protein‑level, functional readouts of oncogenic drivers with rapid turnaround—potentially shortening time to targeted therapy decisions.

Clinical Implications: If prospectively validated, this probe could complement or precede sequencing to stratify patients for EGFR‑TKIs from limited biopsy tissue, improving turnaround in time‑sensitive decisions.

Key Findings

  • Designed a covalent TKI‑derived probe enabling no‑wash real‑time EGFR imaging.
  • Distinguished mutant vs wild‑type tumors in vivo and predicted EGFR mutations in patient tissues with 94% accuracy (98% with IHC).
  • Validated across cells, murine models, and human biopsies.

3. Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.

80.5The New England Journal of Medicine · 2025PMID: 39740051

A descriptive national series of 46 laboratory‑confirmed US H5N1 cases (Mar–Oct 2024) found predominantly mild illness with frequent conjunctivitis (93%), no hospitalizations or deaths, and no detected household transmission among 97 contacts; PPE use in exposed workers was suboptimal. Findings inform occupational PPE priorities and continued genomic/epidemiologic surveillance.

Impact: Timely human clinical and exposure data from an expanding epizootic provide actionable guidance on clinical recognition (ocular presentations), antiviral use, and occupational PPE priorities.

Clinical Implications: Clinicians should include ocular screening in exposed workers, consider early antivirals, and public health must prioritize PPE access/training (notably eye protection) and active surveillance for changes in transmissibility.

Key Findings

  • Among 46 cases, 93% had conjunctivitis; illness was generally mild with no hospitalizations or deaths.
  • No secondary cases detected among 97 household contacts.
  • PPE use among exposed workers was suboptimal (gloves 71%, eye protection 60%, masks 47%).